Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Fibrillin-1 regulates white adipose tissue development, homeostasis, and function.

Muthu ML., Tiedemann K., Fradette J., Komarova S., Reinhardt DP.

Animal Study on Type 2 Diabetes, published in Matrix Biol (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Matrix Biol (2022)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
35533973
DOI
10.1016/j.matbio.2022.05.002

Abstract (original English)

Fibrillin-1 is an extracellular glycoprotein present throughout the body. Mutations in fibrillin-1 cause a wide spectrum of type I fibrillinopathies, including Marfan syndrome characterized by clinical manifestations in adipose tissues, among others. This study addresses the hypothesis that fibrillin-1 regulates adipocyte development and plays a vital role in adipose tissue homeostasis. We employed two mouse models - Fbn1 mgR/mgR (20-25% of normal fibrillin-1) and Fbn1 C1041G/+ (missense mutation in fibrillin-1) to examine the role of fibrillin-1 in adipose tissue development and homeostasis. Fibrillin-1 was detected around mature adipocytes in both mouse and human white adipose tissues. As expected, Fbn1 mgR/mgR mice displayed a significant reduction of fibrillin-1 in white adipose tissue, and no change was observed for Fbn1 C1041G/+ mice, each compared to their respective littermates. Male Fbn1 mgR/mgR mice had more white and brown adipose tissues, whereas female Fbn1 mgR/mgR and both male and female Fbn1 C1041G/+ showed no difference compared to their respective wild-type littermates. Consistent with this data, male Fbn1 mgR/mgR mice displayed hyperinsulinemia and an insulin resistance phenotype with higher levels of cholesterol and high-density lipoproteins in the serum. Fibrillin-1 deficiency in male Fbn1 mgR/mgR mice also promoted adipogenic gene expression and led to hyp

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipogenesisAdipose Tissue, WhiteAnimalsFemaleFibrillin-1Fibrillin-2FibrillinsHomeostasisMaleMarfan Syndrome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research